DAPK1 Gene

DAPK1 — Death-Associated Protein Kinase 1

Overview

DAPK1 (Death-Associated Protein Kinase 1) encodes a calcium/calmodulin-dependent serine/threonine kinase that functions as a positive regulator of [apoptosis](/entities/apoptosis), [autophagy](/entities/autophagy), and programmed cell death. Originally identified as a pro-apoptotic kinase, DAPK1 has emerged as a critical player in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and stroke[@yoo2023].

The kinase is highly expressed in the brain, particularly in neurons, where it integrates calcium signaling with cell death pathways. DAPK1 phosphorylates numerous substrates including [alpha-synuclein](/proteins/alpha-synuclein) at Ser129, [tau](/proteins/tau) proteins, p53, and components of the autophagy machinery. This broad substrate specificity makes DAPK1 a central node connecting multiple neurodegeneration pathways[@ohta2020][@li2022].

Gene Information

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | DAPK1 |
| Full Name | Death-Associated Protein Kinase 1 |
| Chromosomal Location | 9p21.3 |
| NCBI Gene ID | 1612 |
| OMIM | 600730 |
| Ensembl ID | ENSG00000196730 |
| UniProt ID | P53355 |
| Encoded Protein | DAPK1 (1056 amino acids) |
| Protein Family | CaMK (Calcium/Calmodulin-dependent protein kinase) family |
| Associated Diseases | Alzheimer's disease, Parkinson's disease, stroke, epilepsy, cancer |

</div>

DAPK1 — Death-Associated Protein Kinase 1

Overview

DAPK1 (Death-Associated Protein Kinase 1) encodes a calcium/calmodulin-dependent serine/threonine kinase that functions as a positive regulator of [apoptosis](/entities/apoptosis), [autophagy](/entities/autophagy), and programmed cell death. Originally identified as a pro-apoptotic kinase, DAPK1 has emerged as a critical player in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and stroke[@yoo2023].

The kinase is highly expressed in the brain, particularly in neurons, where it integrates calcium signaling with cell death pathways. DAPK1 phosphorylates numerous substrates including [alpha-synuclein](/proteins/alpha-synuclein) at Ser129, [tau](/proteins/tau) proteins, p53, and components of the autophagy machinery. This broad substrate specificity makes DAPK1 a central node connecting multiple neurodegeneration pathways[@ohta2020][@li2022].

Gene Information

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | DAPK1 |
| Full Name | Death-Associated Protein Kinase 1 |
| Chromosomal Location | 9p21.3 |
| NCBI Gene ID | 1612 |
| OMIM | 600730 |
| Ensembl ID | ENSG00000196730 |
| UniProt ID | P53355 |
| Encoded Protein | DAPK1 (1056 amino acids) |
| Protein Family | CaMK (Calcium/Calmodulin-dependent protein kinase) family |
| Associated Diseases | Alzheimer's disease, Parkinson's disease, stroke, epilepsy, cancer |

</div>

Protein Structure and Regulation

Domain Architecture

DAPK1 is a multi-domain protein consisting of:

Activation Mechanism

DAPK1 activity is tightly regulated by calcium/calmodulin binding:

• In resting cells, the calmodulin-regulatory domain autoinhibits kinase activity
• Upon calcium influx, calmodulin binds and relieves autoinhibition
• Sustained calcium signaling leads to persistent DAPK1 activation
• Autophosphorylation at Ser308 maintains activity even after calcium levels normalize

Post-translational Modifications

• Phosphorylation: Multiple sites including Ser308 (autophosphorylation), Thr180 (activation loop)
• Ubiquitination: K63-linked polyubiquitination by TRAF6 promotes kinase activity
• SUMOylation: Modulates subcellular localization and interactions

Normal Physiological Functions

DAPK1 participates in several essential cellular processes:

Apoptosis Induction

• Mediates both extrinsic and intrinsic apoptotic pathways
• Phosphorylates p53 at Ser15, enhancing its transcriptional activity
• Directly activates caspase-3 and caspase-9
• Promotes mitochondrial outer membrane permeabilization (MOMP)

Autophagy Regulation

• Phosphorylates Beclin1 to initiate autophagy
• Modulates ULK1 complex activity
• Participates in both bulk and selective autophagy
• Links autophagy to apoptotic pathways

Cytoskeletal Dynamics

• Modulates actin polymerization and cell motility
• Regulates microtubule dynamics
• Influences cell shape and process extension in neurons

Inflammation and Immunity

• Regulates cytokine production in immune cells
• Modulates NF-κB signaling
• Participates in microglial activation

Role in Alzheimer's Disease

DAPK1 has emerged as a significant contributor to Alzheimer's disease pathogenesis through multiple mechanisms:

Amyloid-beta Induced Neurotoxicity

DAPK1 is upregulated in Alzheimer's disease brains and mediates Aβ-induced neuronal death[@yoo2023]:

• Aβ exposure triggers DAPK1 activation via calcium dysregulation
• DAPK1 phosphorylates p53, enhancing pro-apoptotic gene expression
• DAPK1 deficiency protects neurons from Aβ toxicity in vitro
• DAPK1 knockout mice show reduced neuronal loss in APP/PS1 models

Tau Pathology

DAPK1 phosphorylates tau at multiple sites relevant to AD pathology[@zhang2022][@xu2024]:

• Direct phosphorylation of tau at Ser262 and Ser396
• DAPK1 activity correlates with tau phosphorylation in AD brains
• DAPK1-mediated tau phosphorylation promotes NFT formation
• DAPK1 inhibition reduces tau pathology in animal models

Synaptic Dysfunction

• DAPK1 activation disrupts synaptic plasticity
• Impairs LTP (Long-Term Potentiation) in hippocampal neurons
• Reduces dendritic spine density
• Contributes to memory deficits

Neuroinflammation

DAPK1 in microglia contributes to neuroinflammation[@wang2024]:

• Promotes pro-inflammatory cytokine production
• Enhances NF-κB activation in glial cells
• Creates feedback loop between inflammation and neuronal death
• DAPK1 in microglia may represent therapeutic target

Calcium Dysregulation

AD features prominent calcium dysregulation that activates DAPK1[@yang2023]:

• Amyloid-beta disrupts calcium homeostasis
• Elevated intracellular calcium directly activates DAPK1
• DAPK1 activation creates feed-forward neurodegeneration
• Calcium channel blockers reduce DAPK1 activation

Role in Parkinson's Disease

Alpha-synuclein Phosphorylation

The most significant finding linking DAPK1 to PD is the phosphorylation of α-synuclein at Ser129[@ohta2020]:

• DAPK1 directly phosphorylates α-synuclein at Ser129
• Phosphorylation promotes formation of insoluble aggregates
• DAPK1 enhances rotenone-induced α-synuclein aggregation
• pSer129 α-synuclein is a hallmark of Lewy bodies in PD brains
• DAPK1 inhibition reduces α-synuclein aggregation in cellular models

Mitochondrial Dysfunction

DAPK1 contributes to mitochondrial impairment in PD[@fan2022]:

• DAPK1 activation promotes mitochondrial fragmentation
• Impairs complex I activity in dopaminergic neurons
• Enhances ROS production
• Contributes to PINK1/Parkin pathway dysfunction

Dopaminergic Neuron Survival

• DAPK1 is activated in MPTP and 6-OHDA PD models
• DAPK1 knockout mice show resistance to MPTP toxicity
• DAPK1-mediated apoptosis in dopaminergic neurons
• Genetic variants in DAPK1 may influence PD susceptibility[@yu2021]

Autophagy Impairment

• DAPK1 dysregulates autophagy in PD
• Abnormal autophagy contributes to α-synuclein accumulation
• DAPK1 inhibition restores autophagy flux
• Therapeutic potential of DAPK1 modulators

Role in Stroke and Brain Injury

Ischemic Injury

DAPK1 mediates neuronal death after stroke[@yamamoto2019]:

• Ischemia triggers rapid DAPK1 activation
• DAPK1 deletion reduces infarct size in mouse models
• DAPK1 inhibitors are neuroprotective in stroke models
• DAPK1 acts upstream of both apoptosis and necroptosis

Excitotoxicity

• Glutamate excitotoxicity activates DAPK1
• NMDA receptor overactivation leads to DAPK1-dependent death
• DAPK1 links excitotoxicity to apoptotic pathways
• Calcium influx is the primary activator

Therapeutic Targeting

DAPK1 inhibition represents a therapeutic strategy for stroke:

• Small molecule DAPK1 inhibitors show promise
• Neuroprotective effects in pre-clinical models
• Extended therapeutic window compared to other approaches

Therapeutic Implications

DAPK1 Inhibitors

Multiple DAPK1 inhibitors have been developed[@song2023]:

• ATP-competitive inhibitors block kinase activity
• Peptide inhibitors targeting protein-protein interactions
• Natural products with DAPK1 inhibitory activity
• Challenges include blood-brain barrier penetration

Combination Therapies

• DAPK1 inhibitors with existing AD therapeutics
• Synergy with anti-amyloid and anti-tau approaches
• Multi-target strategies for complex neurodegeneration

Biomarker Potential

• DAPK1 activity as a disease biomarker
• CSF DAPK1 measurement in neurodegenerative diseases
• Monitoring therapeutic response

Expression Patterns

Brain Expression

• High expression: Cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), [basal ganglia](/brain-regions/basal-ganglia), [cerebellum](/brain-regions/cerebellum)
• Cellular localization: Primarily cytosolic, with nuclear translocation upon activation
• Cell type specificity: Neurons, astrocytes, microglia

Peripheral Expression

• Moderate expression in lung, heart, immune cells
• Differential expression in various tissues

Signaling Pathways

DAPK1 interacts with multiple signaling pathways:

Key Protein Interactions

| Interacting Protein | Function | Disease Relevance |
|---------------------|----------|-------------------|
| p53 | Tumor suppressor, apoptosis | AD, PD |
| Beclin1 | Autophagy initiation | AD, PD |
| Alpha-synuclein | Lewy body component | PD |
| Tau | NFT component | AD |
| ULK1 | Autophagy initiation | AD, PD |
| RIPK1 | Necroptosis | Stroke |

Research Directions

Current Research Focus

Unresolved Questions

• Specific contribution of DAPK1 to different neurodegenerative diseases
• Cell-type specific functions (neurons vs. glia)
• Relationship between DAPK1 and other kinases (e.g., CDK5, GSK3β)
• Optimal timing for therapeutic intervention

Cross-Links

Related Mechanisms

• [Apoptosis](/entities/apoptosis) — DAPK1 as pro-apoptotic kinase
• [Autophagy](/mechanisms/autophagy) — DAPK1 in autophagic cell death
• [Alpha-synuclein](/proteins/alpha-synuclein) — DAPK1 phosphorylates α-syn at Ser129
• [Tau](/proteins/tau) — DAPK1 phosphorylates tau
• [Neuroinflammation](/mechanisms/neuroinflammation) — DAPK1 in glial activation
• [Calcium signaling](/mechanisms/calcium-dysregulation) — DAPK1 activation trigger
• [Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction) — DAPK1 effects on mitochondria

Related Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease) — Major disease association
• [Parkinson's Disease](/diseases/parkinsons-disease) — α-synuclein phosphorylation
• [Stroke](/diseases/stroke) — Ischemic neuronal injury

Related Genes

• [p53 (TP53)](/genes/tp53) — DAPK1 phosphorylates p53
• [Beclin1 (BECN1))](/genes/becn1) — DAPK1 regulates autophagy
• [ULK1](/genes/ulk1) — DAPK1 interacts with autophagy initiation complex
• [SNCA](/genes/snca) — Alpha-synuclein gene, DAPK1 substrate

Summary

DAPK1 represents a critical molecular link between calcium dysregulation and neurodegeneration. Its ability to phosphorylate key proteins including α-synuclein, tau, and p53 positions it as a central mediator of cell death pathways in AD, PD, and stroke. The kinase's involvement in multiple disease mechanisms makes it an attractive therapeutic target, though drug development challenges remain. Ongoing research continues to elucidate DAPK1's precise contributions to neurodegeneration and explore its potential for disease modification.

See Also

• [Genes Section](/genes)
• [Proteins Section](/proteins)
• [Mechanisms Section](/mechanisms)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [NCBI Gene Database](https://www.ncbi.nlm.nih.gov/gene/1612)
• [UniProt Protein Database](https://www.uniprot.org/uniprot/P53355)
• [Ensembl Gene Database](https://www.ensembl.org/Homo_sapiens/ENSG00000196730)
• [PubMed Literature](https://pubmed.ncbi.nlm.nih.gov/?term=DAPK1+neurodegeneration)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving DAPK1 Gene discovered through SciDEX knowledge graph analysis: